Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 4, 2014, Pages 505-508

  Nishijima, Yoko ^a   Kobori, Hiroyuki ^a   Kaifu, Kumiko ^a   Mizushige, Tomoko ^a   Hara, Taiga ^a   Nishiyama, Akira ^a   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensinogen; circadian rhythm; CKD; healthy volunteers; plasma; urine

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER; ANGIOTENSIN I;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROTEIN ANALYSIS; PROTEINURIA; URINARY EXCRETION; URINE LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; METABOLISM; NORMAL HUMAN; PATHOPHYSIOLOGY; URINE;

ADULT; ANGIOTENSIN I; ANGIOTENSINOGEN; BIOMARKERS; CIRCADIAN RHYTHM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84918513266     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320314557584     Document Type: Article

References (21)

1. Kobori H, Nangaku M, Navar LG, et al. The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007 ; 59: 251-287
2. Kobori H, Nishiyama A, Abe Y, et al. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension. 2003 ; 41: 592-597
3. Kobori H, Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun. 2004 ; 315: 746-750
4. Kobori H, Ozawa Y, Suzaki Y, et al. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol. 2005 ; 16: 2073-2080
5. Nagai Y, Yao L, Kobori H, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005 ; 16: 703-711
6. Kobori H, Alper AB, Shenava R, et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009 ; 53: 344-350
7. Katsurada A, Hagiwara Y, Miyashita K, et al. Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol. 2007 ; 293: F956 - F960
8. Kala R, Fyhrquist F, Eisalo A. Diurnal variation of plasma angiotensin II in man. Scand J Clin Lab Invest. 1973 ; 31: 363-365
9. Kawasaki T, Ueno M, Uezono K, et al. Differences and similarities among circadian characteristics of plasma renin activity in healthy young women in Japan and the United States. Am J Med. 1980 ; 68: 91-96
10. Nishijima Y, Kobori H, Sofue T, et al. Important aspects of urine sampling for angiotensinogen measurement: Time and preservation conditions in healthy individuals. Tohoku J Exp Med. 2012 ; 228: 333-339
11. Kaifu K, Kobori H, Nishijima Y, et al. The circadian rhythm of plasma angiotensinogen in healthy volunteers. Hypertension. 2012 ; 60: A399
12. Nishijima Y, Kobori H, Mizushige T, et al. Circadian rhythm of plasma and urinary angiotensinogen in patients with chronic kidney disease. Hypertension. 2013 ; 62: A195
13. Navar LG, Prieto MC, Satou R, et al. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol. 2011 ; 11: 180-186
14. Castrop H, Höcherl K, Kurtz A, et al. Physiology of kidney renin. Physiol Rev. 2010 ; 90: 607-673
15. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol. 2001 ; 12: 431-439
16. Saito T, Urushihara M, Kotani Y, et al. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009 ; 338: 478-480
17. Kobori H, Nishiyama A, Harrison-Bernard LM, et al. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension. 2003 ; 41: 42-49
18. Kobori H, Ohashi N, Katsurada A, et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008 ; 2: 349-354
19. Nakano D, Kobori H, Burford JL, et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol. 2012 ; 23: 1847-1856
20. Kamiyama M, Urushihara M, Morikawa T, et al. Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci. 2013 ; 14: 23045-23062
21. Burns KD, Hiremath S. Urinary angiotensinogen as a biomarker of chronic kidney disease: Ready for prime time?. Nephrol Dial Transplant. 2012 ; 27: 3010-3013